Pages that link to "Q35874121"
Jump to navigation
Jump to search
The following pages link to Further evidence for the presence of cannabinoid CB1 receptors in guinea-pig small intestine (Q35874121):
Displaying 50 items.
- Cannabinoids and the Digestive Tract (Q22252841) (← links)
- The endocannabinoid system as an emerging target of pharmacotherapy (Q24648473) (← links)
- Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630 (Q24672356) (← links)
- Cannabinoid receptors and pain (Q28143655) (← links)
- Effects of cannabinoid receptor-2 activation on accelerated gastrointestinal transit in lipopolysaccharide-treated rats (Q28271665) (← links)
- The role of the endocannabinoid system in the pathophysiology and treatment of irritable bowel syndrome (Q28291178) (← links)
- Differential effects of anandamide on acetylcholine release in the guinea-pig ileum mediated via vanilloid and non-CB1 cannabinoid receptors (Q28346747) (← links)
- The endogenous cannabinoid agonist, anandamide stimulates sensory nerves in guinea-pig airways (Q28354238) (← links)
- Pharmacological analysis of cannabinoid receptor activity in the rat vas deferens (Q28360193) (← links)
- Cannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation (Q28361058) (← links)
- Effect of vanilloid drugs on gastrointestinal transit in mice (Q28361178) (← links)
- Effects of cannabinoids on adrenaline release from adrenal medullary cells (Q28363784) (← links)
- Cannabinoids and the gastrointestinal tract (Q28365382) (← links)
- Design and synthesis of the CB1 selective cannabinoid antagonist AM281: a potential human SPECT ligand (Q28366135) (← links)
- The role of cannabinoid receptors in intestinal motility, defaecation and diarrhoea in rats (Q28378072) (← links)
- delta(9)-Tetrahydrocannabinol increases nerve growth factor production by prostate PC-3 cells. Involvement of CB1 cannabinoid receptor and Raf-1. (Q31896948) (← links)
- Discovery and characterization of endogenous cannabinoids (Q33720094) (← links)
- Evidence for the presence of CB1 cannabinoid receptors on peripheral neurones and for the existence of neuronal non-CB1 cannabinoid receptors (Q33720099) (← links)
- Pharmacological characterisation of cannabinoid CB(1) receptors in the rat and mouse. (Q33893580) (← links)
- Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol (Q33900859) (← links)
- Towards cannabinoid drugs--revisited. (Q33906007) (← links)
- The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. (Q34066911) (← links)
- Pharmacological characterization of cannabinoid receptor activity in the rat-isolated ileum myenteric plexus-longitudinal muscle preparation (Q34078746) (← links)
- The cannabinoid antagonist SR144528 enhances the acute effect of WIN 55,212-2 on gastrointestinal motility in the rat. (Q34096898) (← links)
- Molecular probes for the cannabinoid receptors (Q34098959) (← links)
- Cannabinoid receptors and the regulation of immune response (Q34099012) (← links)
- Differential effects of CB(1) neutral antagonists and inverse agonists on gastrointestinal motility in mice (Q34145142) (← links)
- Cannabinoid modulation of peripheral autonomic and sensory neurotransmission (Q34214210) (← links)
- Agonist-antagonist characterization of 6'-cyanohex-2'-yne-delta 8-tetrahydrocannabinol in two isolated tissue preparations. (Q34410764) (← links)
- Modulation of transmitter release via presynaptic cannabinoid receptors (Q34430714) (← links)
- Pharmacology of cannabinoid CB1 and CB2 receptors. (Q34442847) (← links)
- Evidence for the presence of CB2-like cannabinoid receptors on peripheral nerve terminals. (Q34454662) (← links)
- 'Endocannabinoids' and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance. (Q34472174) (← links)
- Cardiovascular effects of cannabinoids (Q34786849) (← links)
- Evidence that methyl arachidonyl fluorophosphonate is an irreversible cannabinoid receptor antagonist (Q35026518) (← links)
- Comparison of cannabinoid binding sites in guinea-pig forebrain and small intestine (Q35028176) (← links)
- In vitro functional evidence of neuronal cannabinoid CB1 receptors in human ileum (Q35028193) (← links)
- Comparison of novel cannabinoid partial agonists and SR141716A in the guinea-pig small intestine (Q35041929) (← links)
- Characterization of the effects of cannabinoids on guinea-pig tracheal smooth muscle tone: role in the modulation of acetylcholine release from parasympathetic nerves (Q35042564) (← links)
- Intestinal lipid-derived signals that sense dietary fat. (Q35183977) (← links)
- Involvement of cannabinoid receptors in gut motility and visceral perception (Q35752224) (← links)
- Evidence for the presence of cannabinoid CB1 receptors in mouse urinary bladder (Q35874137) (← links)
- The role of endocannabinoids in the regulation of gastric emptying: alterations in mice fed a high-fat diet (Q36510027) (← links)
- Inhibitory effect of salvinorin A, from Salvia divinorum, on ileitis-induced hypermotility: cross-talk between kappa-opioid and cannabinoid CB(1) receptors. (Q36977483) (← links)
- Modulation of excitatory synaptic transmission by Delta 9-tetrahydrocannabinol switches from agonist to antagonist depending on firing rate (Q37199151) (← links)
- Prejunctional and peripheral effects of the cannabinoid CB(1) receptor inverse agonist rimonabant (SR 141716). (Q37226537) (← links)
- Cannabinoids: Potential Targets for Bladder Dysfunction (Q37835090) (← links)
- The gastrointestinal pharmacology of cannabinoids: focus on motility (Q38018818) (← links)
- Cannabinoid Receptors in Regulating the GI Tract: Experimental Evidence and Therapeutic Relevance (Q38761437) (← links)
- The gastrointestinal tract - a central organ of cannabinoid signaling in health and disease (Q38937293) (← links)